{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+treatment+to+blind+study", "query": { "intervention": "Placebo treatment to blind study" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6450, "total_pages": 645, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+treatment+to+blind+study&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T11:16:24.335Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05813847", "title": "Herniorrhaphy for Postoperative Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hernia, Inguinal", "Post Operative Pain" ], "interventions": [ { "name": "local anaesthetic injection of CPL-01", "type": "DRUG" }, { "name": "Morphine (rescue medication)", "type": "DRUG" }, { "name": "Acetaminophen (rescue medication)", "type": "DRUG" }, { "name": "Oxycodone (rescue medication)", "type": "DRUG" }, { "name": "local anaesthetic injection of placebo", "type": "DRUG" }, { "name": "local anaesthetic injection of ropivacaine HCl", "type": "DRUG" }, { "name": "Open inguinal hernia repair", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Cali Pharmaceuticals LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 518, "start_date": "2023-04-18", "completion_date": "2025-10-06", "has_results": false, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05813847" }, { "nct_id": "NCT02267135", "title": "Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Scalp Psoriasis" ], "interventions": [ { "name": "Secukinumab 300 mg", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 102, "start_date": "2014-09-29", "completion_date": "2015-12-07", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 17, "location_summary": "Sacramento, California • Aurora, Colorado • Trumbull, Connecticut + 13 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Rockville", "state": "Maryland" }, { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02267135" }, { "nct_id": "NCT00688493", "title": "Effects of Single Oral Dose Dapagliflozin QT Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo to match moxifloxacin and dapagliflozin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 36, "start_date": "2007-07", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2012-03-21", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00688493" }, { "nct_id": "NCT02709655", "title": "Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine 10 mg/day", "type": "DRUG" }, { "name": "Vortioxetine 20 mg/day", "type": "DRUG" }, { "name": "Fluoxetine 20mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "7 Years to 11 Years" }, "enrollment_count": 683, "start_date": "2016-05-18", "completion_date": "2022-01-21", "has_results": true, "last_update_posted_date": "2022-09-22", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Imperial, California • Lemon Grove, California + 29 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Imperial", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709655" }, { "nct_id": "NCT00175825", "title": "A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Brivaracetam", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 210, "start_date": "2005-11-07", "completion_date": "2006-06-29", "has_results": true, "last_update_posted_date": "2018-10-02", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Fresno, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00175825" }, { "nct_id": "NCT00573157", "title": "The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Lupus Nephritis" ], "interventions": [ { "name": "Atacicept", "type": "DRUG" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 6, "start_date": "2007-12", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-03-23", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 12, "location_summary": "New Orleans, Louisiana • Shreveport, Louisiana • Detroit, Michigan + 9 more", "locations": [ { "city": "New Orleans", "state": "Louisiana" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Manhasset", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573157" }, { "nct_id": "NCT02970019", "title": "Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "K0706", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharma Advanced Research Company Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2017-03-30", "completion_date": "2019-05-28", "has_results": false, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 5, "location_summary": "Long Beach, California • Panorama City, California • DeLand, Florida + 2 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Panorama City", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02970019" }, { "nct_id": "NCT01192906", "title": "A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "bitopertin [RO4917838]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 624, "start_date": "2010-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 21, "location_summary": "Carson, California • Oceanside, California • San Diego, California + 17 more", "locations": [ { "city": "Carson", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01192906" }, { "nct_id": "NCT02616315", "title": "Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Weight Regain Post Bariatric Surgery" ], "interventions": [ { "name": "Naltrexone HCl/Bupropion HCl Placebo", "type": "DRUG" }, { "name": "Naltrexone HCl/Bupropion HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2016-02", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 2, "location_summary": "Chicago, Illinois • Boston, Massachusetts", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02616315" }, { "nct_id": "NCT02087917", "title": "A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Hypercholesterolemia" ], "interventions": [ { "name": "HS-25", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zhejiang Hisun Pharmaceutical Co. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 376, "start_date": "2014-03", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-01-06", "last_synced_at": "2026-09-29T11:16:24.335Z", "location_count": 27, "location_summary": "Chandler, Arizona • Phoenix, Arizona • West Hills, California + 24 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "West Hills", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02087917" } ] }